share_log

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics股价上涨,公司宣布已在Bria-OTS的1/2期研究中给第一个患者投药。
Benzinga ·  11:47

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics宣布在Bria-OTS的1/2期研究中为第一位患者注射剂量后,该公司股价走高。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发